Showing results (71-80 of 413) with videos related to
Sort By:
Pageof 42
Current Opinion in Investigational Drugs (London, England : 2000)|December 16, 2010
Vedolizumab, a humanized mAb against the α4β7 integrin for the potential treatment of ulcerative colitis and Crohn's diseaseHerbert Tilg, Arthur KaserExpert Opinion on Therapeutic Targets|February 25, 2009
Inflammatory bowel diseases: highlights from the United European Gastroenterology Week 2008Arthur Kaser, Herbert TilgNature Clinical Practice. Gastroenterology & Hepatology|November 3, 2005
Treatment strategies in nonalcoholic fatty liver diseaseHerbert Tilg, Arthur KaserCurrent Drug Delivery|October 26, 2011
"Metabolic aspects" in inflammatory bowel diseasesArthur Kaser, Herbert TilgEuropean Journal of Gastroenterology & Hepatology|November 20, 2002
Splanchnic blood flow determination in patients with suspected chronic intestinal ischaemiaHerbert Tilg, Hannes GaenzerAnnual Review of Medicine|October 31, 2025
Potential Health Risks of Artificial SweetenersMaria Effenberger, Herbert TilgCancer Cell|February 15, 2022
Lactobacillus reuteri-an old acquaintance takes on a new task in colorectal tumor surveillanceChristina Watschinger, Alexander R MoschenNutrients|May 2, 2020
Prebiotic Effects of Partially Hydrolyzed Guar Gum on the Composition and Function of the Human Microbiota-Results from the PAGODA TrialSimon J Reider, Simon Moosmang, Judith Tragust, et al.Liver International : Official Journal of the International Association for the Study of the Liver|April 20, 2020
Dimethyl fumarate ameliorates hepatic inflammation in alcohol related liver diseaseMoris Sangineto, Felix Grabherr, Timon E Adolph, et al.European Cytokine Network|February 12, 2010
Influence of significant weight loss on serum matrix metalloproteinase (MMP)-7 levelsClaudia Ress, Alexander Tschoner, Christian Ciardi, et al.Pageof 42